Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction.

[1]  Juan Sanchís,et al.  Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST , 2004 .

[2]  V. Bodí,et al.  [Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome]. , 2004, Revista espanola de cardiologia.

[3]  J. Núñez,et al.  Why does C-reactive protein increase in non-ST elevation acute coronary syndromes? Role of myocardial damage. , 2003, International journal of cardiology.

[4]  J. Núñez,et al.  Indicadores pronósticos del síndrome coronario agudo sin elevación del segmento ST , 2003 .

[5]  R. Califf,et al.  Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. , 2003, Journal of the American College of Cardiology.

[6]  A. Siegbahn,et al.  Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease. , 2003, European heart journal.

[7]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[8]  J. Núñez,et al.  Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda , 2002 .

[9]  J. Núñez,et al.  [Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants]. , 2002, Revista espanola de cardiologia.

[10]  Michael R Cusack,et al.  Systemic inflammation in unstable angina is the result of myocardial necrosis. , 2002, Journal of the American College of Cardiology.

[11]  P. Mills,et al.  The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. , 2001, Journal of the American College of Cardiology.

[12]  A. Siegbahn,et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[13]  J. Tijssen,et al.  C-Reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of tests early after the onset of chest pain. , 2000, Clinical chemistry.

[14]  C. Heeschen,et al.  Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. , 2000, Journal of the American College of Cardiology.

[15]  C. Boissonnet,et al.  Independent prognostic value of elevated C-reactive protein in unstable angina. , 1999, Circulation.

[16]  E. Antman,et al.  C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy , 1998 .

[17]  A. Siegbahn,et al.  Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 1997, Circulation.

[18]  A. Rebuzzi,et al.  Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. , 1996, Circulation.

[19]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.